Theravance Biopharma, Inc. (TBPH)
16.22
-0.29
(-1.76%)
USD |
NASDAQ |
May 15, 16:00
16.23
+0.01
(+0.06%)
After-Hours: 20:00
Theravance Biopharma Profit Margin (Quarterly) : -27.87% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Viatris, Inc. | 5.01% |
| Relmada Therapeutics, Inc. | -- |
| Indivior Pharmaceuticals, Inc. | 28.08% |
| Corcept Therapeutics, Inc. | -18.92% |
| Assertio Holdings, Inc. | -189.8% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 47.30% |
| Return on Assets | 26.72% |
| Return on Invested Capital | 37.44% |
| Gross Profit Margin (Quarterly) | 91.88% |
| Operating Margin (Quarterly) | -46.88% |
| Return on Net Operating Assets | 176.3% |